Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Paulden

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
BMC Health Services Research|August 7, 2012
Specialized multi-disciplinary heart failure clinics in Ontario, Canada: an environmental scanHarindra C Wijeysundera, Gina Trubiani, Lusine Abrahamyan, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 19, 2015
Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer TreatmentBeate Jahn, Ursula Rochau, Christina Kurzthaler, et al.
Pharmacoeconomics|May 13, 2022
Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age GroupsEllen Rafferty, Mike Paulden, Sarah A Buchan, et al.
The Lancet. Global Health|September 21, 2023
Challenges of calculating cost-effectiveness thresholdsLaura Vallejo-Torres, Karl Claxton, Laura C Edney, et al.
Pharmacoeconomics|September 29, 2021
Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level EstimatesLaura C Edney, James Lomas, Jonathan Karnon, et al.
The Gulf Journal of Oncology|March 15, 2021
Impact and Cost-Effectiveness of Oncotype DX for Guiding Adjuvant Chemotherapy Decisions in Early Breast CancerFadi El Karak, Elie Rassy, Josiane Bassil, et al.
BMC Cancer|October 18, 2017
Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!OnlineBeate Jahn, Ursula Rochau, Christina Kurzthaler, et al.
Systematic Reviews|July 25, 2014
Early economic evaluation of emerging health technologies: protocol of a systematic reviewBa' Pham, Hong Anh Thi Tu, Dolly Han, et al.
Surgery|June 21, 2011
Support surfaces for intraoperative prevention of pressure ulcers in patients undergoing surgery: a cost-effectiveness analysisBa' Pham, Laura Teague, James Mahoney, et al.
Plos One|October 6, 2022
Prediction of odds for emergency cesarean section: A secondary analysis of the CHILD term birth cohort studyMon H Tun, Radha Chari, Padma Kaul, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
BMC Health Services Research|August 7, 2012
Specialized multi-disciplinary heart failure clinics in Ontario, Canada: an environmental scanHarindra C Wijeysundera, Gina Trubiani, Lusine Abrahamyan, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 19, 2015
Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer TreatmentBeate Jahn, Ursula Rochau, Christina Kurzthaler, et al.
Pharmacoeconomics|May 13, 2022
Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age GroupsEllen Rafferty, Mike Paulden, Sarah A Buchan, et al.
The Lancet. Global Health|September 21, 2023
Challenges of calculating cost-effectiveness thresholdsLaura Vallejo-Torres, Karl Claxton, Laura C Edney, et al.
Pharmacoeconomics|September 29, 2021
Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level EstimatesLaura C Edney, James Lomas, Jonathan Karnon, et al.
The Gulf Journal of Oncology|March 15, 2021
Impact and Cost-Effectiveness of Oncotype DX for Guiding Adjuvant Chemotherapy Decisions in Early Breast CancerFadi El Karak, Elie Rassy, Josiane Bassil, et al.
BMC Cancer|October 18, 2017
Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!OnlineBeate Jahn, Ursula Rochau, Christina Kurzthaler, et al.
Systematic Reviews|July 25, 2014
Early economic evaluation of emerging health technologies: protocol of a systematic reviewBa' Pham, Hong Anh Thi Tu, Dolly Han, et al.
Surgery|June 21, 2011
Support surfaces for intraoperative prevention of pressure ulcers in patients undergoing surgery: a cost-effectiveness analysisBa' Pham, Laura Teague, James Mahoney, et al.
Plos One|October 6, 2022
Prediction of odds for emergency cesarean section: A secondary analysis of the CHILD term birth cohort studyMon H Tun, Radha Chari, Padma Kaul, et al.
Pageof 8